<a href="#hui-cai">Hui Cai</a>, Program Chair, VP and Head of Content, WuXi AppTec

Welcome 

<a href="#steve-yang">Steve Yang</a>, Co-CEO, WuXi AppTec
<a href="#frederick-chew">Frederick Chew</a>, CEO, A*STAR; Chief, Public Sector Science &amp; Technology Policy &amp; Plans Office, Prime Minister’s Office of Singapore
<a href="#george-vradenburg">George Vradenburg</a>, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman &amp; Co-Founder, UsAgainstAlzheimer’s

Opening Remarks

<a href="#kate-bingham">Kate Bingham</a>, Managing Partner, SV Health Investors
<a href="#luigi-ferrucci">Luigi Ferrucci</a>, Scientific Director, National Institute on Aging of NIH
<a href="#paul-irving">Paul Irving</a>, Chairman, Milken Institute Center for the Future of Aging; Distinguished Scholar-in-Residence, USC Davis School of Gerontology
Session Leader:  <a href="#michal-preminger">Michal Preminger</a>, Regional Head, Johnson &amp; Johnson Innovation East North America

Aging: The Grand Challenge

<a href="#niranjan-bose">Niranjan Bose</a>, Managing Director, Health &amp; Life Sciences, Gates Ventures
<a href="#ivan-cheung">Ivan Cheung</a>, Chairman, Eisai Inc; Global President of Neurology Business Group, Eisai Co Ltd
<a href="#george-vradenburg">George Vradenburg</a>, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman &amp; Co-Founder, UsAgainstAlzheimer’s
Session Leader:  <a href="#stacie-weninger">Stacie Weninger</a>, President of F-Prime Biomedical Research Initiative (FBRI)

Spotlight on Alzheimer’s Disease

<a href="#linda-partridge">Linda Partridge</a>, Founding Director, Max Planck Institute for Biology of Ageing; Professor, Institute of Healthy Ageing, and GEE, UCL
<a href="#eric-verdin">Eric Verdin</a>, CEO &amp; President, Buck Institute for Research on Aging
Session Leader: <a href="#sebastien-thuault">Sebastien Thuault</a>, Chief Editor, Nature Aging

State of Aging Research

<a href="#yap-seng-chong">Yap-Seng Chong</a>, Dean, NUS Yong Loo Lin School of Medicine; Chief Clinical Officer, A*STAR
<a href="#daniel-fung">Daniel Fung</a>, CEO, Institute of Mental Health in Singapore
<a href="#chien-earn-lee">Chien-Earn Lee</a>, Deputy Group CEO (Regional Health System), SingHealth
<a href="#andrea-maier">Andrea Maier</a>, Co-Director, Centre for Healthy Longevity, National University Health System, Singapore
Session Leader: <a href="#brian-kennedy">Brian Kennedy</a>, Distinguished Professor in Biochemistry and Physiology, the Yong Loo Lin School of Medicine, National University of Singapore

Healthy Aging: Singapore’s Perspectives 

A conversation between <a href="#scott-berkowitz">Scott Berkowitz</a>, VP &amp; Chief Population Health Officer, Johns Hopkins Medicine; Associate Professor of Cardiology, Johns Hopkins University and <a href="#henry-brodaty">Henry Brodaty</a>, Professor of Ageing and Mental Health; Co-Director, CHeBA (Centre for Healthy Brain Ageing), UNSW Sydney

Prevention. Prediction. Personalization.

<a href="#rita-balice-gordon">Rita Balice-Gordon</a>, CEO, Muna Therapeutics
<a href="#marco-boorsma">Marco Boorsma</a>, General Partner at Forbion
<a href="#jens-eckstein">Jens Eckstein</a>, Managing Partner, Apollo Health Ventures
<a href="#kristen-fortney">Kristen Fortney</a>, Co-Founder and CEO, BioAge
<a href="#james-peyer">James Peyer</a>, Founder &amp; CEO, Cambrian Biopharma
Session Leader: <a href="#dave-madge">Dave Madge</a>, VP of Discovery Services, WuXi AppTec

The Next Frontiers in Tackling Age-Related Disorders

<a href="#joseph-coughlin">Joseph Coughlin</a>, Founder and Director, MIT AgeLab

How Will Technologies Shape the New Era of Healthy Aging

Closing 

HAF_Astar1200X628_1208

Rising to the Challenge: Healthy Aging Forum 2022

Welcome

<a href="#minzhang-chen">Minzhang Chen</a>, Co-CEO, WuXi AppTec

Opening Remarks 

<a href="#david-berry">David Berry</a>, Founder and CEO, Valo Health
<a href="#diego-miralles">Diego Miralles</a>, CEO, Laronde
<a href="#roger-perlmutter">Roger Perlmutter</a>, Chairman &amp; CEO, Eikon Therapeutics
<a href="#henrijette-richter">Henrijette Richter</a>, Managing Partner, Sofinnova Partners
Session Leader: <a href="#jorge-conde">Jorge Conde</a>, General Partner, Andreessen Horowitz

Opening Plenary: Changing the Games of R&D Productivity 

A Conversation between <a href="#susan-galbraith">Susan Galbraith</a>, EVP, Oncology R&amp;D, AstraZeneca and <a href="#david-reese">David Reese</a>, EVP of R&amp;D, Amgen

A Special Tribute to Dr. José Baselga 

A Conversation with <a href="#james-wilson">James Wilson</a>, Professor of Medicine and Pediatrics of Department of Medicine, and Director of Gene Therapy Program, University of Pennsylvania. Moderated by <a href="#john-carroll">John Carroll</a>, Chief Editor &amp; Founder, Endpoints News

A Special Tribute to Dr. Tachi Yamada 

<a href="#christiana-bardon">Christiana Bardon</a>, Co-Managing Partner of BioImpact Capital, MPM Capital
<a href="#Jürgen-eckhardt">Jürgen Eckhardt</a>, SVP and Head of Leaps by Bayer
<a href="#alice-pomponio">Alice Pomponio</a>, Managing Director, American Cancer Society BrightEdge
<a href="#glenn-rockman">Glenn Rockman</a>, Founder and Managing Partner, Adjuvant Capital
Session Leader: <a href="#laura-kleiman">Laura Kleiman</a>, Founder and CEO, Reboot Rx

Investing for Social Impact

<a href="#debora-barton">Debora Barton</a>, CMO, Carisma Therapeutics
<a href="#john-houston">John Houston</a>, President and CEO, Arvinas
<a href="#eric-kelsic">Eric Kelsic</a>, Founder &amp; CEO, Dyno Therapeutics
<a href="#devyn-smith">Devyn Smith</a>, CEO, Arbor Biotechnologies
Session Leader: <a href="#ryan-cawood">Ryan Cawood</a>, CSO, WuXi Advanced Therapies and OXGENE

Delivering on the Promise of New Modalities

A Conversation with <a href="#todd-golub">Todd Golub</a>, Director, Broad Institute of MIT &amp; Harvard. Moderated by <a href="#kevin-davies">Kevin Davies</a>, Executive Editor, The CRISPR Journal and GEN Biotechnology; and Author, Editing Humanity

Closing Keynote 

WGF2022_Banner_Final

WuXi Global Forum 2022

Dialogues on Healthy Aging Banner_eventbrite_featured

Live Now! Join Global Leaders for “Dialogues on Healthy Aging”

<a href="#hui-cai">Hui Cai</a>, VP and Head of Content, WuXi AppTec
<a href="#pat-furlong">Pat Furlong</a>, Founding President &amp; CEO, Parent Project Muscular Dystrophy
<a href="#debra-miller">Debra Miller</a>, CEO &amp; Founder, CureDuchenne
<a href="#filippo-buccella">Filippo Buccella</a>, Founder, Parent Project Italy APS
<a href="#huigu-chen">Huigu Chen</a>, President, Shanghai Jiai Myopathy Care Center, China
<a href="#tali-kaplan">Tali Kaplan</a>, Co-Founder &amp; CEO, Little Steps Association for Patients with Duchenne &amp; Becker Muscular Dystrophy, Israel
<a href="#sherena-loh">Sherena Loh</a>, Director, Muscular Dystrophy Association (Singapore)

 Welcome

<a href="#kevin-flanigan">Kevin Flanigan</a>, Director, Center for Gene Therapy, Professor, Pediatrics &amp; Neurology, Nationwide Children’s Hospital
<a href="#stanley-nelson">Stanley Nelson</a>, Professor of Human Genetics, Center for Duchenne Muscular Dystrophy, David Geffen School of Medicine at UCLA
<a href="#richard-parad">Richard Parad</a>, Associate Professor of Pediatrics, Harvard Medical School, Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital
Moderator: <a href="#hawken-miller">Hawken Miller</a>, Features Writer, BioNews

Clinical Research and Practices 

A Conversation between<a href="#pat-furlong"> Pat Furlong</a>, Founding President &amp; CEO, Parent Project Muscular Dystrophy and<a href="#debra-miller"> Debra Miller</a>, CEO &amp; Founder, CureDuchenne

Patient Story - The Nilson Family 

<a href="#michael-binks">Michael Binks</a>, VP &amp; Head of Clinical Research in the Rare Disease Research Unit at Pfizer
<a href="#paula-clemens">Paula Clemens</a>, Professor &amp; Vice Chair, Neurology, University of Pittsburgh School of Medicine
<a href="#nathalie-goemans">Nathalie Goemans</a>, Professor, Neuromuscular Reference Centre for Children, Department of Pediatric Neurology, University Hospitals Leuven, Belgium
Moderator: <a href="#timothy-franson">Timothy Franson</a>, Principal, Faegre Drinker Consulting and formerly VP Global Regulatory Affairs, Eli Lilly &amp; Co and Chief Medical Officer of YourEncore

What can we do to bring medicines to DMD patients around the world faster? 

<a href="#rhonda-bassel-duby">Rhonda Bassel-Duby</a>, Professor, Department of Molecular Biology, University of Texas Southwestern Medical Center
<a href="#ashish-dugar">Ashish Dugar</a>, SVP &amp; Global Head of Medical Affairs, Dyne Therapeutics
<a href="#jane-larkindale">Jane Larkindale</a>, VP, Clinical Sciences, PepGen
<a href="#art-levin">Art Levin</a>, CSO, Avidity Biosciences
<a href="#stuart-peltz">Stuart Peltz</a>, Founder &amp; CEO, PTC Therapeutics
Moderator: <a href="#richard-soll">Richard Soll</a>, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

New Targets. New Modalities. New Directions. 

<a href="#michael-binks">Michael Binks</a>, VP &amp; Head of Clinical Research in the Rare Disease Research Unit at Pfizer
<a href="#yi-dai">Yi Dai</a>, Associate Professor, Department of Neurology, Peking Union Medical College Hospital, China
<a href="#xihua-li">Xihua Li</a>, Director, Department of Neuromuscular Disease, Children’s Hospital of Fudan University, China
<a href="#stanley-nelson">Stanley Nelson</a>, Professor of Human Genetics, Center for Duchenne Muscular Dystrophy, David Geffen School of Medicine at UCLA
<a href="#richard-parad">Richard Parad</a>, Associate Professor of Pediatrics, Harvard Medical School, Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital
<a href="#stacey-tay">Stacey Tay</a>, Senior Consultant, Department of Paediatrics, Khoo Teck Puat &#8211; National University Children&#8217;s Medical Institute, National University Hospital, Singapore

10-Year Vision 

<a href="#hui-cai">Hui Cai</a>, VP and Head of Content, WuXi AppTec

1485X973

DMD: Charting the Path for New Therapeutics and Better Care

<a href="#hui-cai">Hui Cai</a>, Program Chair, VP and Head of Content, WuXi AppTec
<a href="#katie-clapp">Katie Clapp</a>, President &amp; Co-Founder, FRAXA Research Foundation

<a href="#katie-clapp">Katie Clapp</a>, President &amp; Co-Founder, FRAXA Research Foundation
<a href="#alison-singer">Alison Singer</a>, President, Autism Science Foundation
<a href="#wendy-bruce">Wendy Bruce</a>, Executive Director, Fragile X Association of Australia
<a href="#yinan-ma">Yinan Ma</a>, VP, Fragile X Association of China
<a href="#karen-kelm">Karen Kelm</a>, Board Member, Fragile X Foundation of Canada
<a href="#shalini-kedia">Shalini Kedia</a>, Chairperson, Fragile X Society – India
<a href="#sabrina-muggiati">Sabrina Muggiati</a>, Creator of the Eu Digo X Program – Brazil
<a href="#paula-gómez-ortega">Paula Gómez Ortega</a>, Coordinator, Fragile X Syndrome Parent&#8217;s Group – Argentina
<a href="#sandz-fraser">Sandz Fraser</a>, Coordinator, Fragile X South Africa; Owner &amp; Trustee, FiX Africa Special Needs Homeschool
<a href="#nazhi-tabatadze">Nazhi Tabatadze</a>, Clinic coordinator at Fragile X Center, Georgia
<a href="#andrea-lee">Andrea Lee</a>, Executive Director, Fragile X New Zealand

Collaboration and the voices of the patient advocacy groups 

<a href="#craig-erickson">Craig Erickson</a>, Professor of Clinical Psychiatry, Cincinnati Children&#8217;s Hospital and the University of Cincinnati College of Medicine
<a href="#randi-hagerman">Randi Hagerman</a>, Medical Director, MIND Institute; Distinguished Professor of Pediatrics, Endowed Chair, Fragile X Research, UC Davis Health
<a href="#elizabeth-berry-kravis">Elizabeth Berry-Kravis</a>, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center
Moderator: <a href="#ted-brown">Ted Brown</a>, President, Fragile X Association of Australia

Current clinical studies and practice

Patient story: 3 Australian families

<a href="#neil-thompson">Neil Thompson</a>, CSO, Healx
<a href="#mark-bear">Mark Bear</a>, Professor of Neuroscience, Picower Institute for Learning and Memory, MIT
<a href="#mark-gurney">Mark Gurney</a>, Chairman &amp; CEO, Tetra Therapeutics
<a href="#walter-kaufmann">Walter Kaufmann</a>, CMO, Anavex Life Sciences; Adjunct Professor of Human Genetics, Emory University
<a href="#charles-large">Charles Large</a>, CEO, Autifony Therapeutics
Moderator:<a href="#richard-soll"> Richard Soll</a>, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

New directions in Fragile X Syndrome therapeutics

Patient story: The Goss family

<a href="#michael-tranfaglia">Michael Tranfaglia</a>, Medical Director &amp; CSO, FRAXA Research Foundation
<a href="#alison-singer">Alison Singer</a>, President, Autism Science Foundation
<a href="#nahum-sonenberg">Nahum Sonenberg</a>, Professor &amp; Gilman Cheney Chair in Biochemistry, Goodman Cancer Research Centre, McGill University
<a href="#peter-kind">Peter Kind</a>, Director, Simons Initiative for the Developing Brain, Patrick Wild Centre; Professor of Developmental Neuroscience, University of Edinburgh
<a href="#sumantra-chattarji">Sumantra Chattarji</a>, Senior Professor, National Centre for Biological Sciences, Tata Institute of Fundamental Science, Bangalore, India
<a href="#patricia-cogram">Patricia Cogram</a>, Associate Professor, Department of Genetics, IEB, Faculty of Science, University of Chile
<a href="#shangzhi-huang">Shangzhi Huang</a>, Professor of Medical Genetics, Peking Union Medical College
<a href="#elizabeth-berry-kravis">Elizabeth Berry-Kravis</a>, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center

10-year vision 

Closing

WXPRESS1485X973

Fragile X Syndrome: In Pursuit of a Cure

<a href="#michael-hayden">Michael Hayden</a>, Founder &amp; CEO, Prilenia Therapeutics; Killam Professor at the University of British Columbia
Moderator: <a href="#michael-ward">Michael Ward</a>, Global Head of Life Sciences &amp; Healthcare Thought Leadership, Clarivate

Huntington’s Disease: Challenges, Lessons, and Opportunities 

<a href="#karen-anderson">Karen Anderson</a>, Professor, Psychiatry &amp; Neurology, Georgetown University; Director, HD Care, Education and Research Center
<a href="#blair-leavitt">Blair Leavitt</a>, Professor, Department of Medical Genetics and Senior Scientist, Centre for Molecular Medicine and Therapeutics, UBC
<a href="#svein-olaf-osen">Svein Olaf Osen</a>, President, International Huntington Association
<a href="#kristen-powers">Kristen Powers</a>, Executive Producer, Twitch
Moderator: <a href="#richard-soll">Richard Soll</a>, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

The Evolving Landscape of Care in Huntington’s Disease 

<a href="#irina-antonijevic">Irina Antonijevic</a>, CMO, Triplet Therapeutics
<a href="#ricardo dolmetsch">Ricardo Dolmetsch</a>, President, Research &amp; Development, uniQure
<a href="#aimee-jackson">Aimee Jackson</a>, CSO, Atalanta Therapeutics
Moderator: <a href="#dave-madge">Dave Madge</a>, VP, Research Service Division, WuXi AppTec

Events

Rising to the Challenge: Healthy Aging Forum 2022

Events

WuXi Global Forum 2022

WuXi Global Forum

Episode I: Tackling Alzheimer’s Disease with Scale, System & Speed

Events

Episode II: Building Paths Towards Healthy Aging Through Innovation: An Industry Perspective

Events

Episode III: The Future of Aging: Challenges & Opportunities

Events

Episode IV: How Research & Education Can Impact an Aging Society: A Singapore Perspective

Events

Live Now! Join Global Leaders for “Dialogues on Healthy Aging”

Events

EVENT RECAP

DMD: Charting the Path for New Therapeutics and Better Care

Events

Featured

Live Now! Join Global Leaders for “Dialogues on Healthy Aging”

Events

DMD: Charting the Path for New Therapeutics and Better Care

Events

Fragile X Syndrome: In Pursuit of a Cure

Events

Winning the War on Huntington’s Disease

Events

WuXi Rare Disease Awareness Concert 2021

Events

WuXi Healthcare Forum 2021

Events